Which Weight Management Injection Offers Better Value?
Wegovy Price UK vs Mounjaro: Understanding Your Treatment Options
When comparing Wegovy price UK versus Mounjaro costs, you're evaluating two distinct yet effective approaches to prescription weight management. Wegovy contains semaglutide, a GLP-1 receptor agonist, whilst Mounjaro utilises tirzepatide, which targets both GLP-1 and GIP receptors. This dual mechanism may offer different clinical benefits, though both require careful dose escalation and ongoing medical supervision.
The pricing structures reflect their different dosing schedules: Wegovy follows a 5-step escalation (0.25mg to 2.4mg) over 16 weeks, while Mounjaro uses 6 doses (2.5mg to 15mg) with flexible timing. Understanding these differences helps explain why Wegovy price UK calculations often appear more straightforward for treatment planning. Both treatments are prescription-only medicines requiring clinical assessment through our MHRA-compliant process.
Detailed Wegovy Price UK Breakdown vs Mounjaro Costs
Current Wegovy price UK for individual pens ranges from £79.99 (0.25mg starter dose with FIRST40 code) to £209.99 (2.4mg maintenance dose). Our bundle options provide convenient multi-month supplies: the Intro Trio (0.25mg, 0.5mg, 1mg) costs £299.99, while the Ultimate Stability Trio (three 2.4mg pens) is £649.99. These prices include discount application at checkout, eliminating surprise costs.
Mounjaro pricing follows a similar premium structure, with maintenance doses commanding higher prices due to increased manufacturing complexity. Both treatments represent significant monthly investments, typically ranging £200-400 during maintenance phases. EverydayMeds offers both options because individual response varies—your prescriber can recommend the most suitable choice based on your medical history and treatment goals.
Clinical Evidence: Wegovy Price UK Justified by STEP Trial Results
The STEP clinical trial programme demonstrates why Wegovy price UK reflects substantial research investment. In STEP 1, participants taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo. STEP 5 showed sustained clinically studied weight loss at two years, indicating long-term efficacy.
Mounjaro's SURMOUNT trials reported similar impressive results, though direct comparison isn't appropriate due to different trial designs. Both treatments have undergone rigorous MHRA evaluation, with Wegovy receiving additional cardiovascular benefits recognition through the SELECT trial, showing 20% reduction in major cardiovascular events (Wilding et al., NEJM, 2021).
How Wegovy Works: Understanding Your Investment
Wegovy functions as a GLP-1 receptor agonist, mimicking your body's natural incretin hormone that regulates blood sugar and appetite. When injected weekly using the FlexTouch pen device, semaglutide activates receptors in your brain's appetite centres, promoting feelings of fullness after smaller meals. This mechanism may reduce food cravings and slow gastric emptying, helping you feel satisfied longer. The treatment works synergistically with reduced-calorie diets and increased physical activity—it's designed to support, not replace, lifestyle modifications. Understanding this mechanism helps justify the Wegovy price UK investment as a sophisticated medical intervention rather than a simple appetite suppressant.
Streamlined Ordering Process for Both Treatments
Accessing either treatment through EverydayMeds begins with our 3-minute online clinical assessment, covering medical history, current medications, and weight management goals. Our UK-qualified prescribers review applications within 3 working days (express 24-hour service available), ensuring appropriate treatment selection. Once approved, we dispatch via next-day delivery using temperature-controlled cold-chain logistics, maintaining medication integrity from our GPhC-registered facilities (#9012878). Payment includes consultation, prescription, and delivery—no hidden charges affecting your Wegovy price UK calculations. Both treatments require ongoing monitoring, with follow-up assessments scheduled according to clinical guidelines.
Storage and Practical Considerations
Wegovy offers a practical storage advantage over Mounjaro: once removed from refrigeration, Wegovy pens remain stable for 6 weeks at room temperature below 30°C, compared to Mounjaro's 21-day limit. This flexibility particularly benefits frequent travellers or those with unreliable refrigeration. Both use pre-filled pen devices with hidden needles, making self-injection straightforward. The weekly injection schedule (same day each week) helps establish routine, though injection sites should be rotated between thigh, abdomen, and upper arm. Proper storage maintains medication potency, protecting your Wegovy price UK investment throughout the treatment course.
UK Market Position: Why EverydayMeds Stocks Both Options
The UK weight management landscape benefits from having both Wegovy and Mounjaro available, as individual responses vary significantly. Some patients respond better to semaglutide's single-pathway approach, while others benefit from tirzepatide's dual receptor targeting. This variability explains why Wegovy price UK and Mounjaro costs remain competitive—neither represents a universally superior option.
EverydayMeds stocks both treatments specifically because clinical choice matters more than cost alone. Your prescriber can recommend switches if initial response proves unsatisfactory, and our pharmacy maintains stock levels ensuring treatment continuity. This dual availability represents a significant advantage over pharmacies stocking only one option.
Making Your Treatment Investment Decision
Choosing between treatments shouldn't focus solely on Wegovy price UK versus Mounjaro costs—clinical suitability takes precedence. Both represent substantial financial commitments, typically requiring 6-12 months minimum for meaningful results. Our clinical team considers your medical history, previous weight loss attempts, concurrent medications, and lifestyle factors when recommending treatment. Whether you proceed with Wegovy's proven semaglutide formulation or Mounjaro's innovative dual-pathway approach, EverydayMeds ensures professional support throughout your weight management journey. Use code FIRST40 (new customers) or DOSE25 (returning patients) at checkout, and begin your clinical assessment at https://everydaymeds.co.uk/collections/weight-loss today.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
